Signal Amplification at the Rhodopsin-To-Transducin

Total Page:16

File Type:pdf, Size:1020Kb

Signal Amplification at the Rhodopsin-To-Transducin LETTER REPLY TO HECK ET AL.: Signal amplification at the rhodopsin-to- LETTER transducin·phosphodiesterase step in rod phototransduction K.-W. Yaua,1, W. W. S. Yueb, and D. Silvermana In PNAS (1), we estimate ∼12–14 active transducin· In point iia, Heck et al. question our analysis of the phosphodiesterase complexes (GT*·PDE*s) produced data in figure 3A, right (1), pointing out the disparity in per active rhodopsin (Rho*) in mouse rods. This is the waveform between the ensemble variance and the en- effective gain—more informative by not including the semble mean square of the flash responses. We do empty gain from GT*s failing to activate PDE. Nearly not completely disagree about possibly some small dis- all previous estimates were on the total number of GT* parity between the two waveforms, but these measure- produced per Rho* merely because no one before ments were difficult, given the small variance (10 times us could measure the individual GT*·PDE*-triggered smaller than that in WT experiments). Moreover, instead electrical event for direct comparison with the single- of stemming necessarily from variability in the underly- Rho* response. ing elementary events as Heck et al. suggest, the dis- We do not state in our paper that previous crepancy may come from variability in the timing of measurements of the rate of GT* production per Rho* activation of individual GT molecules by REY-Rho* due were all incorrect, but rather they spanned a wide to the much reduced affinity between REY-Rho* and GT. range of values with no consensus regarding which Point iib questions a constancy of the GT*·PDE*- value is valid, owing to the different experimental triggered events produced by apo-opsin (Opn*), pro- preparations, methodologies, temperature, interpre- posing instead a stochastic variability in event size/wave- tations, etc. [see SI appendix in our paper (1)]. Most form, but admits that it is not straightforward to take this importantly, unlike previous work, we obtained our into account in the analysis. Given no a priori evidence data exclusively from intact, live rods, and thus our for stochastic variations, we extracted the average event results are more straightforward to interpret. Heck size and shape by adopting the simplest model of fairly et al.’s Letter (2) selects without justification particular constant events. This possibility is not unfounded but values from a wide range to claim agreement with guided by our previous findings on olfactory trans- ours and fails to recognize the significance of our find- duction (6), where the response to Golf*·AC*(adenylyl ings in the broader history of the problem. cyclase)—functionally equivalent to GT*·PDE* in vision— Regarding specific point i in Heck et al.’s Letter, appears quite constant in amplitude and waveform. the authors again selectively discuss just one model Furthermore, the time-integrated single-GT*·PDE*– [namely, their own (3, 4)] out of several about func- triggered responses from our two independent meth- tional symmetry/asymmetry of PDE. This model is ods match each other well (figure 7B in ref. 1). neither recent (see ref. 5) nor widely accepted in In sum, relative to the “historical,” textbook-dogma the field currently because of limited experimental value of 500 (7), we do consider our value very low and evidence. Our paper provides an unbiased discus- would still consider it low even if our estimate were, say, sion of this and other models. higher by another factor of 2. aSolomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205; and bDepartment of Physiology, University of California, San Francisco, CA 94158 Author contributions: K.-W.Y., W.Y., and D.S. designed research; W.Y. and D.S. performed research; W.Y. and D.S. analyzed data; and K.-W.Y., W.Y., and D.S. wrote the paper. The authors declare no conflict of interest. Published under the PNAS license. 1To whom correspondence should be addressed. Email: [email protected]. Published online April 30, 2019. www.pnas.org/cgi/doi/10.1073/pnas.1904339116 PNAS | April 30, 2019 | vol. 116 | no. 18 | 8655–8656 Downloaded by guest on September 26, 2021 1 Yue WWS, et al. (2019) Elementary response triggered by transducin in retinal rods. Proc Natl Acad Sci USA 116:5144–5153. 2 Heck M, Hofmann KP, Kraft TW, Lamb TD (2019) Phototransduction gain at the G-protein, transducin, and effector protein, phosphodiesterase-6, stages in retinal rods. Proc Natl Acad Sci USA 116:8653–8654. 3 Lamb TD, Heck M, Kraft TW (2018) Implications of dimeric activation of PDE6 for rod phototransduction. Open Biol 8:180076. 4 Qureshi BM, et al. (2018) It takes two transducins to activate the cGMP-phosphodiesterase 6 in retinal rods. Open Biol 8:180075. 5 Bennett N, Clerc A (1989) Activation of cGMP phosphodiesterase in retinal rods: mechanism of interaction with the GTP-binding protein (transducin). Biochemistry 28:7418–7424. 6 Bhandawat V, Reisert J, Yau K-W (2005) Elementary response of olfactory receptor neurons to odorants. Science 308:1931–1934. 7 Vuong TM, Chabre M, Stryer L (1984) Millisecond activation of transducin in the cyclic nucleotide cascade of vision. Nature 311:659–661. 8656 | www.pnas.org/cgi/doi/10.1073/pnas.1904339116 Yau et al. Downloaded by guest on September 26, 2021.
Recommended publications
  • Identification of Residues of the H-Ras Protein Critical for Functional Interaction with Guanine Nucleotide Exchange Factors RAYMOND D
    MOLECULAR AND CELLULAR BIOLOGY, Feb. 1994, p. 1104-1112 Vol. 14, No. 2 0270-7306/94/$04.00+0 Copyright © 1994, American Society for Microbiology Identification of Residues of the H-Ras Protein Critical for Functional Interaction with Guanine Nucleotide Exchange Factors RAYMOND D. MOSTELLER, JAEWON HAN, AND DANIEL BROEK* Department ofBiochemistry and Molecular Biology, Kenneth Norris Jr. Cancer Hospital and Research Center, University of Southern California School ofMedicine, Los Angeles, California 90033 Received 10 September 1993/Returned for modification 21 October 1993/Accepted 29 October 1993 Ras proteins are activated in vivo by guanine nucleotide exchange factors encoded by genes homologous to the CDC25 gene ofSaccharomyces cerevisiae. We have taken a combined genetic and biochemical approach to probe the sites on Ras proteins important for interaction with such exchange factors and to further probe the mechanism ofCDC25-catalyzed GDP-GTP exchange. Random mutagenesis coupled with genetic selection in S. cerevisiae was used to generate second-site mutations within human H-ras-alalS which could suppress the ability of the Ala-15 substitution to block CDC25 function. We transferred these second-site suppressor mutations to normal H-ras and oncogenic H-rasva1l2 to test whether they induced a general loss of function or whether they selectively affected CDC25 interaction. Four highly selective mutations were discovered, and they affected the surface-located amino acid residues 62, 63, 67, and 69. Two lines of evidence suggested that these residues may be involved in binding to CDC25: (i) using the yeast two-hybrid system, we demonstrated that these mutants cannot bind CDC25 under conditions where the wild-type H-Ras protein can; (ii) we demonstrated that the binding to H-Ras of monoclonal antibody Y13-259, whose epitope has been mapped to residues 63, 65, 66, 67, 70, and 73, is blocked by the mouse sosl and yeast CDC25 gene products.
    [Show full text]
  • G-Protein ␤␥-Complex Is Crucial for Efficient Signal Amplification in Vision
    The Journal of Neuroscience, June 1, 2011 • 31(22):8067–8077 • 8067 Cellular/Molecular G-Protein ␤␥-Complex Is Crucial for Efficient Signal Amplification in Vision Alexander V. Kolesnikov,1 Loryn Rikimaru,2 Anne K. Hennig,1 Peter D. Lukasiewicz,1 Steven J. Fliesler,4,5,6,7 Victor I. Govardovskii,8 Vladimir J. Kefalov,1 and Oleg G. Kisselev2,3 1Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri 63110, Departments of 2Ophthalmology and 3Biochemistry and Molecular Biology, Saint Louis University School of Medicine, Saint Louis, Missouri 63104, 4Research Service, Veterans Administration Western New York Healthcare System, and Departments of 5Ophthalmology (Ross Eye Institute) and 6Biochemistry, University at Buffalo/The State University of New York (SUNY), and 7SUNY Eye Institute, Buffalo, New York 14215, and 8Sechenov Institute for Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, Saint Petersburg 194223, Russia A fundamental question of cell signaling biology is how faint external signals produce robust physiological responses. One universal mechanism relies on signal amplification via intracellular cascades mediated by heterotrimeric G-proteins. This high amplification system allows retinal rod photoreceptors to detect single photons of light. Although much is now known about the role of the ␣-subunit of the rod-specific G-protein transducin in phototransduction, the physiological function of the auxiliary ␤␥-complex in this process remains a mystery. Here, we show that elimination of the transducin ␥-subunit drastically reduces signal amplification in intact mouse rods. The consequence is a striking decline in rod visual sensitivity and severe impairment of nocturnal vision. Our findings demonstrate that transducin ␤␥-complex controls signal amplification of the rod phototransduction cascade and is critical for the ability of rod photoreceptors to function in low light conditions.
    [Show full text]
  • Transducin ␤-Subunit Can Interact with Multiple G-Protein ␥-Subunits to Enable Light Detection by Rod Photoreceptors
    New Research Sensory and Motor Systems Transducin ␤-Subunit Can Interact with Multiple G-Protein ␥-Subunits to Enable Light Detection by Rod Photoreceptors Paige M. Dexter,1 Ekaterina S. Lobanova,2 Stella Finkelstein,2 William J. Spencer,1 Nikolai P. Skiba,2 and Vadim Y. Arshavsky1,2 DOI:http://dx.doi.org/10.1523/ENEURO.0144-18.2018 1Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina 27710 and 2Albert Eye Research Institute, Duke University, Durham, North Carolina 27710 Visual Overview The heterotrimeric G-protein transducin mediates visual signaling in vertebrate photoreceptor cells. Many aspects of the function of transducin were learned from knock-out mice lacking its individual subunits. Of particular interest is ␥ ␥ the knockout of its rod-specific -subunit (G 1). Two stud- ies using independently generated mice documented that this knockout results in a considerable Ͼ60-fold reduction in the light sensitivity of affected rods, but provided dif- ␣ ␣ ferent interpretations of how the remaining -subunit (G t) ␤ ␥ mediates phototransduction without its cognate G 1 1- subunit partner. One study found that the light sensitivity ␣ reduction matched a corresponding reduction in G t con- tent in the light-sensing rod outer segments and proposed ␣ ␤ that G t activation is supported by remaining G 1 asso- ciating with other G␥ subunits naturally expressed in pho- toreceptors. In contrast, the second study reported the same light sensitivity loss but a much lower, only approx- ␣ imately sixfold, reduction of G t and proposed that the light responses of these rods do not require G␤␥ at all. To resolve this controversy and elucidate the mechanism ␥ driving visual signaling in G 1 knock-out rods, we analyzed both mouse lines side by side.
    [Show full text]
  • Constitutively Active Mutant of Rod A-Transducin in Autosomal Dominant
    HUMAN MUTATION Mutation in Brief #970 (2007) Online MUTATION IN BRIEF p.Gln200Glu, a Putative Constitutively Active Mutant of Rod α-Transducin (GNAT1) in Autosomal Dominant Congenital Stationary Night Blindness Viktoria Szabo1,2†, Hans-Jürgen Kreienkamp1†, Thomas Rosenberg3, and Andreas Gal1* 1Institut für Humangenetik, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany; 3Gordon Norrie Centre for Genetic Eye Diseases, The National Eye Clinic for the Visually Impaired, Hellerup, Denmark; 2Permanent address: Department of Ophthalmology, Semmelweis University, Budapest, Hungary *Correspondence to: A. Gal, Institut für Humangenetik, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany; Tel.: 49-40-42803-2120; Fax: 49-40-42803-5138; E-mail: [email protected] Grant sponsor: Recognition Award of the Alcon Research Institute (Fort Worth, TX, to A.G.) and the German Academic Exchange Service (to V.S.). †Viktoria Szabo and Hans-Jürgen Kreienkamp contributed equally to this work. Communicated by Mark H. Paalman Congenital stationary night blindness (CSNB) is a non-progressive Mendelian condition resulting from a functional defect in rod photoreceptors. A small number of unique missense mutations in the genes encoding various members of the rod phototransduction cascade, e.g. rhodopsin (RHO), cGMP phosphodiesterase β-subunit (PDE6B), and transducin α-subunit (GNAT1) have been reported to cause autosomal dominant (ad) CSNB. While the RHO and PDE6B mutations result in constitutively active proteins, the only known adCSNB-associa- ted GNAT1 change (p.Gly38Asp) produces an α-transducin that is unable to activate its downstream effector molecule in vitro. In a multigeneration Danish family with adCSNB, we identified a novel heterozygous C to G transversion (c.598C>G) in exon 6 of GNAT1 that should result in a p.Gln200Glu substitution in the evolutionarily highly conserved Switch 2 region of α-transducin, a domain that has an important role in binding and hydrolyzing GTP.
    [Show full text]
  • Multi-Functionality of Proteins Involved in GPCR and G Protein Signaling: Making Sense of Structure–Function Continuum with In
    Cellular and Molecular Life Sciences (2019) 76:4461–4492 https://doi.org/10.1007/s00018-019-03276-1 Cellular andMolecular Life Sciences REVIEW Multi‑functionality of proteins involved in GPCR and G protein signaling: making sense of structure–function continuum with intrinsic disorder‑based proteoforms Alexander V. Fonin1 · April L. Darling2 · Irina M. Kuznetsova1 · Konstantin K. Turoverov1,3 · Vladimir N. Uversky2,4 Received: 5 August 2019 / Revised: 5 August 2019 / Accepted: 12 August 2019 / Published online: 19 August 2019 © Springer Nature Switzerland AG 2019 Abstract GPCR–G protein signaling system recognizes a multitude of extracellular ligands and triggers a variety of intracellular signal- ing cascades in response. In humans, this system includes more than 800 various GPCRs and a large set of heterotrimeric G proteins. Complexity of this system goes far beyond a multitude of pair-wise ligand–GPCR and GPCR–G protein interactions. In fact, one GPCR can recognize more than one extracellular signal and interact with more than one G protein. Furthermore, one ligand can activate more than one GPCR, and multiple GPCRs can couple to the same G protein. This defnes an intricate multifunctionality of this important signaling system. Here, we show that the multifunctionality of GPCR–G protein system represents an illustrative example of the protein structure–function continuum, where structures of the involved proteins represent a complex mosaic of diferently folded regions (foldons, non-foldons, unfoldons, semi-foldons, and inducible foldons). The functionality of resulting highly dynamic conformational ensembles is fne-tuned by various post-translational modifcations and alternative splicing, and such ensembles can undergo dramatic changes at interaction with their specifc partners.
    [Show full text]
  • Interaction of a G Protein with an Activated Receptor Opens the Interdomain Interface in the Alpha Subunit
    Interaction of a G protein with an activated receptor opens the interdomain interface in the alpha subunit Ned Van Epsa,1, Anita M. Preiningerb,1, Nathan Alexanderc,1, Ali I. Kayab, Scott Meierb, Jens Meilerc,2, Heidi E. Hammb,2, and Wayne L. Hubbella,2 aJules Stein Eye Institute and Department of Chemistry and Biochemistry, University of California, Los Angeles, CA 90095-7008; bDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232-6600; and cDepartment of Chemistry, Vanderbilt University, Nashville, TN 37232-6600 Contributed by Wayne L. Hubbell, April 14, 2011 (sent for review March 12, 2011) In G-protein signaling, an activated receptor catalyzes GDP/GTP exchange on the Gα subunit of a heterotrimeric G protein. In an initial step, receptor interaction with Gα acts to allosterically trigger GDP release from a binding site located between the nucleotide binding domain and a helical domain, but the molecular mechan- ism is unknown. In this study, site-directed spin labeling and double electron–electron resonance spectroscopy are employed to reveal a large-scale separation of the domains that provides a direct pathway for nucleotide escape. Cross-linking studies show that the domain separation is required for receptor enhancement of nucleotide exchange rates. The interdomain opening is coupled to receptor binding via the C-terminal helix of Gα, the extension of which is a high-affinity receptor binding element. signal transduction ∣ structural polymorphism he α-subunit (Gα) of heterotrimeric G proteins (Gαβγ) med- Tiates signal transduction in a variety of cell signaling pathways Fig. 1. Receptor activation of G proteins leads to a separation between (1).
    [Show full text]
  • GTP-Binding Proteins • Heterotrimeric G Proteins
    GTP-binding proteins • Heterotrimeric G proteins • Small GTPases • Large GTP-binding proteins (e.g. dynamin, guanylate binding proteins, SRP- receptor) GTP-binding proteins Heterotrimeric G proteins Subfamily Members Prototypical effect Gs Gs, Golf cAMP Gi/o Gi, Go, Gz cAMP , K+-current Gq Gq, G11, G14, Inositol trisphosphate, G15/16 diacylglycerol G12/13 G12, G13 Cytoskeleton Transducin Gt, Gustducin cGMP - phosphodiesterase Offermanns 2001, Oncogene GTP-binding proteins Small GTPases Family Members Prototypical effect Ras Ras, Rap, Ral Cell proliferation; Cell adhesion Rho Rho, Rac, CDC42 Cell shape change & motility Arf/Sar Arf, Sar, Arl Vesicles: fission and fusion Rab Rab (1-33) Membrane trafficking between organelles Ran Ran Nuclear membrane plasticity Nuclear import/export The RAB activation-inactivation cycle REP Rab escort protein GGT geranylgeranyl-transferase GDI GDP-dissociation inhibitor GDF GDI displacementfactor Lipid e.g. RAS e.g. ARF1 modification RAB, Gi/o of GTP-binding proteins Lipid modification Enzyme Reaction Myristoylation N-myristoyl-transferase myristoylates N-terminal glycin Farnesylation Farnesyl-transferase, Transfers prenyl from prenyl-PPi Geranylgeranylation geranylgeranyltransferase to C-terminal CAAX motif Palmitoylation DHHC protein Cysteine-S-acylation General scheme of coated vesicle formation T. J. Pucadyil et al., Science 325, 1217-1220 (2009) Published by AAAS General model for scission of coated buds T. J. Pucadyil et al., Science 325, 1217-1220 (2009) Published by AAAS Conformational change in Arf1 and Sar1 GTPases, regulators of coated vesicular transport This happens if protein is trapped in the active conformation Membrane tubules formed by GTP- bound Arf1 Membrane tubules formed by GTP-bound Sar1 Published by AAAS T.
    [Show full text]
  • How Activated Receptors Couple to G Proteins
    Commentary How activated receptors couple to G proteins Heidi E. Hamm* Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232-6600 protein-coupled receptors (GPCRs) vide several new approaches to these ques- Gare involved in the control of every tions and important new information aspect of our behavior and physiology. about the active conformation of rhodop- This is the largest class of receptors, with sin and how it contacts the G protein several hundred GPCRs identified thus (13–15, 35). far. Examples are receptors for hormones Rhodopsin signal transduction in rods such as calcitonin and luteinizing hor- and cones underlies our ability to see both mone or neurotransmitters such as sero- in dim light (rod vision) and in color (cone tonin and dopamine. G protein-coupled vision). Different rhodopsins absorb light receptors can be involved in pathological maximally at different light wavelengths, processes as well and are linked to numer- and on activation they activate rod or cone ous diseases, including cardiovascular and transducins. Transducins activate rod and mental disorders, retinal degeneration, cone cGMP phosphodiesterases, causing cancer, and AIDS. More than half of all rapid light-activated cGMP breakdown, drugs target GPCRs and either activate or resultant closure of cGMP-sensitive chan- inactivate them. Binding of specific li- nels, and photoreceptor cell hyperpolar- gands, such as hormones, neurotransmit- ization and inhibition of photoreceptor ters, chemokines, lipids, and glycopro- neurotransmitter release. The study of teins, activates GPCRs by inducing or visual signal transduction has provided stabilizing a new conformation in the recep- many firsts. The major breakthroughs in tor (1, 2).
    [Show full text]
  • Gi- and Gs-Coupled Gpcrs Show Different Modes of G-Protein Binding
    Gi- and Gs-coupled GPCRs show different modes of G-protein binding Ned Van Epsa, Christian Altenbachb,c, Lydia N. Caroa,1, Naomi R. Latorracad,e,f,g, Scott A. Hollingsworthd,e,f,g, Ron O. Drord,e,f,g, Oliver P. Ernsta,h,2, and Wayne L. Hubbellb,c,2 aDepartment of Biochemistry, University of Toronto, Toronto, ON M5S 1A8, Canada; bStein Eye Institute, University of California, Los Angeles, CA 90095; cDepartment of Chemistry and Biochemistry, University of California, Los Angeles, CA 90095; dDepartment of Computer Science, Stanford University, Stanford, CA 94305; eDepartment of Structural Biology, Stanford University, Stanford, CA 94305; fDepartment of Molecular and Cellular Physiology, Stanford University, Stanford, CA 94305; gInstitute for Computational and Mathematical Engineering, Stanford University, Stanford, CA 94305; and hDepartment of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada Contributed by Wayne L. Hubbell, January 17, 2018 (sent for review December 20, 2017; reviewed by David S. Cafiso and Thomas P. Sakmar) More than two decades ago, the activation mechanism for the differing only by specific side-chain interactions, or is there a membrane-bound photoreceptor and prototypical G protein-coupled specificity code in the receptor involving the allowed magnitude of receptor (GPCR) rhodopsin was uncovered. Upon light-induced changes displacement of particular helices? Of considerable interest are in ligand–receptor interaction, movement of specific transmembrane GPCRs which couple to multiple G-protein subtypes and can helices within the receptor opens a crevice at the cytoplasmic surface, sample diverse conformational landscapes. allowing for coupling of heterotrimeric guanine nucleotide-binding In the present study, SDSL and double electron–electron reso- proteins (G proteins).
    [Show full text]
  • GNAT1 Gene G Protein Subunit Alpha Transducin 1
    GNAT1 gene G protein subunit alpha transducin 1 Normal Function The GNAT1 gene provides instructions for making a protein called alpha (a )-transducin. This protein is one part (the alpha subunit) of a protein complex called transducin. There are several versions of transducin made up of different subunits. Each version is found in a particular cell type in the light-sensitive tissue at the back of the eye (the retina), where it plays a role in transmitting visual signals from the eye to the brain. The transducin complex that contains a -transducin is found only in specialized light receptor cells in the retina called rods. Rods are responsible for vision in low-light conditions. When light enters the eye, a rod cell protein called rhodopsin is turned on ( activated), which then activates a -transducin. Once activated, a -transducin breaks away from the transducin complex in order to activate another protein called cGMP-PDE, which triggers a series of chemical reactions that create electrical signals. These signals are transmitted from rod cells to the brain, where they are interpreted as vision. Health Conditions Related to Genetic Changes Autosomal dominant congenital stationary night blindness At least two mutations in the GNAT1 gene have been found to cause autosomal dominant congenital stationary night blindness, which is characterized by the inability to see in low light. One of these mutations impairs the protein's ability to activate cGMP-PDE; the other mutation results in a protein that is constantly turned on (constitutively activated). Both of these mutations disrupt the pathway that creates visual signals to be sent from rod cells to the brain.
    [Show full text]
  • Directing Gene Expression to Gustducin-Positive Taste Receptor Cells
    The Journal of Neuroscience, July 15, 1999, 19(14):5802–5809 Directing Gene Expression to Gustducin-Positive Taste Receptor Cells Gwendolyn T. Wong, Luis Ruiz-Avila, and Robert F. Margolskee Howard Hughes Medical Institute, Department of Physiology and Biophysics, The Mount Sinai School of Medicine, New York, New York 10029 We have demonstrated that an 8.4 kb segment (GUS8.4 )from Expression of the lacZ transgene from the GUS8.4 promoter and the upstream region of the mouse a-gustducin gene acts as a of endogenous gustducin was coordinately lost after nerve fully functional promoter to target lacZ transgene expression to section and simultaneously recovered after reinnervation, con- the gustducin-positive subset of taste receptor cells (TRCs). firming the functionality of this promoter. Transgenic expression a The GUS8.4 promoter drove TRC expression of the of rat -gustducin restored responsiveness of gustducin null b-galactosidase marker at high levels and in a developmentally mice to both bitter and sweet compounds, demonstrating the appropriate pattern. The gustducin minimal 1.4 kb promoter utility of the gustducin promoter. (GUS1.4 ) by itself was insufficient to specify TRC expression. We also identified an upstream enhancer from the distal portion Key words: gustducin; taste receptor cells; guanine nucleo- of the murine gustducin gene that, in combination with the tide binding regulatory proteins; gustation; transgenic mice; minimal promoter, specified TRC expression of transgenes. promoter identification; b-galactosidase Current models of taste perception in humans suggest four or five sensory cells of the stomach, duodenum, and pancreas (Ho¨fer et primary taste submodalities: sweet, bitter, salty, sour, and umami al., 1996; Ho¨fer and Drenckhahn, 1998).
    [Show full text]
  • G Protein Mutations in Endocrine Diseases
    European Journal of Endocrinology (2001) 145 543±559 ISSN 0804-4643 INVITED REVIEW G protein mutations in endocrine diseases Andrea Lania, Giovanna Mantovani and Anna Spada Institute of Endocrine Sciences, Ospedale Maggiore IRCCS, University of Milan, Via F. Sforza 35, 20122 Milano, Italy (Correspondence should be addressed to A Spada, Istituto di Scienze Endocrine, Pad. Granelli, Ospedale Maggiore IRCCS, Via Francesco Sforza 35, 20122 Milano, Italy; Email: [email protected]) Abstract This review summarizes the pathogenetic role of naturally occurring mutations of G protein genes in endocrine diseases. Although in vitro mutagenesis and transfection assays indicate that several G proteins have mitogenic potential, to date only two G proteins have been identi®ed which harbor naturally occurring mutations, Gsa, the activator of adenylyl cyclase and Gi2a, which is involved in several functions, including adenylyl cyclase inhibition and ion channel modulation. The gene encoding Gsa (GNAS1) may be altered by loss or gain of function mutations. Indeed, heterozygous inactivating germ line mutations in this gene cause pseudohypoparathyroidism type Ia, in which physical features of Albright hereditary osteodystrophy (AHO) are associated with resistance to several hormones, i.e. PTH, TSH and gonadotropins, that activate Gs-coupled receptors or pseudopseudohypoparathyroidism in which AHO is the only clinical manifestation. Evidence suggests that the variable and tissue-speci®c hormone resistance observed in PHP Ia may result from tissue- speci®c imprinting of the GNAS1 gene, although the Gsa knockout model only in part reproduces the human AHO phenotype. Activating somatic Gsa mutations leading to cell proliferation have been identi®ed in endocrine tumors constituted by cells in which cAMP is a mitogenic signal, i.e.
    [Show full text]